Breaking News

Agilent Invests $22M in Newport, DE Manufacturing Facility

Produces liquid chromatography columns for chemical and biochemical analysis, drug discovery, environmental control, and analytical chemistry.

Agilent Technologies Inc., a company involved in analytical instrumentation development and manufacturing, will modernize and expand its Newport, DE manufacturing facility to meet growing demand for its biopharma consumables. Agilent plans to invest nearly $22 million to increase the capacity of its lab-based manufacturing site in Newport, leasing 12,000 sq.-ft. adjacent to its existing facility and fitting out 9,900 sq.-ft. as lab space with new infrastructure, equipment, and instrumentation...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters